(Q42248914)

English

Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China

scientific article published on 23 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Li-Shuai Qu

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jing Zhu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Tao-Tao Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Xi-Zhong Shen

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Tao-Yang Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Zheng-Pin Ni

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Run-Zhou Ni

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Cui-Hua Lu

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

23 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1186-1195

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatocellular carcinoma and hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

The core promoter of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Specific mutations of hepatitis B virus in plasma predict liver cancer development

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Hepatitis B virus genetic variability and evolution.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Predicting the development of hepatocellular cancer in hepatitis B carriers

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12291

21 January 2018

Identifiers

10.1111/HEPR.12291

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42248914&oldid=1940101367"